SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001829126-22-016172
Filing Date
2022-08-25
Accepted
2022-08-25 16:19:58
Documents
1
Period of Report
2022-08-15

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2324
  Complete submission text file 0001829126-22-016172.txt   3699
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1047 SEWARD AVE. WESTFIELD NJ 07090
Business Address
McMurdo Matthew Charles (Reporting) CIK: 0001943108 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-13341 | Film No.: 221197631